1. Re-underwrite a big winner on today's fundamentals, not on the size of the gain
The repeatable method
- When a position has run hard, resist letting the percentage gain drive the decision. Restart the analysis from scratch: value it against current fundamentals as if deciding whether to buy it here.
- Compare how the business has performed to what the original thesis projected — revenue vs guidance, margins vs expectation, forward growth vs the entry assumptions.
- Only sell/trim on thesis-breaking evidence you can name in advance (see insight 4), not on the discomfort of an unrealized gain. If the business is beating the thesis and the valuation is still reasonable, "hold the full position."
- Concede the option to take a little off for the risk-averse — without abandoning the core.
Here: QNST +57% in five months; rather than bank it, Haymaker re-checked the fundamentals — revenue growing faster than guided, margins expanding ahead of plan, ~0.8× forward revenue "not at all stretched" — and concluded "we are holding the full position… will revisit sizing after the Aug 6 report," with "no objection to cutting back a bit" for the cautious.
Watch for
- A winner still cheap on forward numbers with fundamentals ahead of the original thesis — a hold, not an automatic trim.
2. Buy a cyclical trough the market is pricing as a structural decline
The repeatable method
- Find a business whose revenue has collapsed because its customers pulled back spending for cyclical reasons — not because the business itself was impaired.
- Confirm the operation is intact (competitive position, platform, balance sheet) and that the spending cut is reversible — identify the specific catalyst that reopens the customers' budgets.
- Verify the company is first in line to capture the recovery (structural advantage in how the spend flows), then buy while it trades near trough valuation (a fraction of normalized sales).
Here: auto insurers slashed marketing in 2022–23 while repricing their books, cutting QNST revenue from ~$500M and the stock to $11.25 (<0.7× sales); performance marketing is "where those reopened budgets flow first," so as carrier combined ratios healed the budgets returned — "a cyclical trough… being priced as a structural decline."
Watch for
- Customer-driven (not company-driven) revenue collapse, a reversible spending cycle with a datable catalyst, and a business positioned to capture the reopening first.
3. Switch the valuation lens from sales to EBITDA once the margin story becomes the thesis
The repeatable method
- At entry, a deep-value name is often valued on sales (the only clean metric when margins are depressed). As it re-rates, ask what the incremental driver of further upside is.
- If the next leg is margin expansion, move to an EBITDA multiple — model a normalized margin on a forward revenue base, then apply a peer-group EBITDA multiple to get an implied market cap.
- Use the company's own sequential margin trajectory (last quarter vs guided next quarter) as evidence the assumption is conservative, not aggressive.
- Frame the result as an implied cap vs today's cap to size the medium-term opportunity.
Here: at $17.31 QNST is "far from overvalued" on ~1.0× sales, but Haymaker argues "the most relevant framework at this stage is EBITDA multiple rather than revenue multiple" — a 12–15% margin on $1.5B revenue → ~$180–225M EBITDA → $2.7–4.1B implied cap at 15–18× vs ~$1.0B today (Q3 8.6% margin → Q4 guide 11.1% supplies the trajectory).
Watch for
- A re-rated deep-value name where the remaining upside is margin, not multiple — value it on normalized EBITDA and compare the implied cap to today's.
4. Weight an insider sale as a data point, not a verdict — and pre-commit your sell triggers
The repeatable method
- Treat a single insider sale as context, not a thesis-breaker — executives sell for planned liquidity, tax and compensation reasons. Note it explicitly (don't hide it), especially on a position up big and near a 52-week high.
- Separately, write down the specific, observable events that would break the thesis — then hold as long as none appear.
- Check each named trigger against current data before acting; "we do not see any of those signals" is a valid, disciplined reason to keep holding.
Here: QNST's CFO sold 22,057 shares in June — "worth noting… does not change our view." Haymaker's pre-set trim triggers: carrier spending pulling back, HomeBuddy integration distracting from the core insurance business, or a Q4 miss implying over-confident guidance — none currently visible.
Watch for
- A lone insider sale on a runner (context, not exit) alongside a written list of concrete, checkable thesis-breakers.
5. Source ideas from a proven "super investor," then verify with the whole cohort
The repeatable method
- Keep a short list of investors with a documented track record of shared winners; weight their new ideas up front.
- When one flags a name, check whether they surfaced a cohort of related names — a shared, structural bull point across several is stronger corroboration than any single call.
- Look for the common mechanism that should drive all of them (here, cash-flow-funded buybacks), and confirm the companies are actually executing it.
Here: QNST came from Sy Jacobs, whose insurance-marketplace cohort EVER (+59.7%) and MAX (+37.8%) are also winning on the same engine — "abundant free cash flow… offers them the ability to affect substantial share buybacks… exactly what they've been doing." (Sy's GOLD is flagged as a pulled-back add.)
Watch for
- A trusted source's cohort of related names sharing one structural driver that all three are visibly executing.
6. Add to a beaten-down commodity when the bearish narrative rests on a misread
The repeatable method
- When a commodity/resource position falls, isolate the specific narrative the market is selling on — state it in one sentence.
- Test that narrative against the actual facts. If it rests on an event that didn't happen (or reversed), the selling is mispriced fear, not fundamentals.
- Find the substitution/scarcity link that the bears ignored (here, coal competes with LNG; trapped LNG raises coal demand) and corroborate with a supply-side data point.
- Act with urgency when the divergence between narrative and facts is widest — "time is of the essence" — averaging in on the names already owned and initiating the ones missed.
Here: YACAF (−23%) and New Hope (NHC, ~flat) sold off on "misguided optimism about the re-opening of the Strait of Hormuz"; but with LNG "trapped in the Persian Gulf," coal-as-substitute demand rises, and bullish Indonesia (top thermal-coal exporter) supply news adds to it — so Haymaker urges adding/initiating now.
Watch for
- A one-sentence bear narrative that the facts contradict, a substitution or scarcity link the sellers ignored, and a supply-side corroborator — the setup to add into weakness.